aggressive-variant prostate carcinomas
Showing 1 - 25 of 8,211
Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial
Recruiting
- Aggressive Variant Prostate Carcinoma
- +9 more
- Ipilimumab
- Valemetostat
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2022
Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)
Active, not recruiting
- Prostate Cancer Aggressiveness
- Prostate Carcinoma
- Cabazitaxel
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)
Not yet recruiting
- Prostate Cancer
- ADI-PEG 20
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 16, 2023
Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)
Not yet recruiting
- Prostate Cancer Metastatic
- Pembrolizumab
- +2 more
- (no location specified)
Sep 29, 2022
Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston
Recruiting
- Aggressive Variant Prostate Carcinoma
- +5 more
- Cabazitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 10, 2022
A Research Registry on Aggressive PitNETs
Recruiting
- Endocrine Tumor
-
Lyon, FranceHospices Civils de Lyon - Groupement Hospitalier Est
Aug 4, 2023
Analyzing Composition of Tears and Blood for Discovery of Novel
Active, not recruiting
- Prostate Cancer
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jan 6, 2023
Prostate Cancer Trial in Fort-de-France (HOXB13 c.853delT mutation)
Recruiting
- Prostate Cancer
- HOXB13 c.853delT mutation
-
Fort-de-France, MartiniqueCentre Hospitalier Universitaire de Martinique
Aug 3, 2022
Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,
Not yet recruiting
- Localized Prostate Carcinoma
- +3 more
- Degarelix
- MRI-guided transurethral ultrasound ablation (TULSA)
-
Turku, Southwest Finland, FinlandTurku University Hospital
Jun 14, 2023
Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)
Recruiting
- Genitourinary Cancer
- +7 more
-
La Jolla, California
- +5 more
Jul 5, 2022
Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- XmAb20717 + carboplatin + cabazitaxel
- +2 more
-
Duarte, California
- +9 more
May 24, 2022
Prostate Cancer Trial in Detroit (Educational video)
Not yet recruiting
- Prostate Cancer
- Educational video
-
Detroit, MichiganHenry Ford Cancer Pavilion
Jul 14, 2023
Epiction of Genomic and Genetic Landscape Identifies CCL5
Completed
- Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
- (no location specified)
Jan 27, 2023
Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))
Active, not recruiting
- Prostate Cancer
- Multiparametric magnetic resonance imaging (mpMRI)
-
Taoyuan, TaiwanLi-Jen Wang
Nov 9, 2023
Prostate Cancer Trial in Washington (Proactive Streamlined Genetic Education and Testing, Usual Care)
Completed
- Prostate Cancer
- Proactive Streamlined Genetic Education and Testing
- Usual Care
-
Washington, District of ColumbiaGeorgetown University Medical Center/Lombardi Comprehensive Canc
Jan 4, 2023
Prostate Cancer Trial in London
Recruiting
- Prostate Cancer
-
London, United KingdomUniversity College London
Jul 28, 2022
Prostate Active Surveillance Study
Recruiting
- Prostatic Neoplasms
-
San Francisco, California
- +9 more
Jul 5, 2022
Decipher® Testing - VANDAAM Study
Recruiting
- Prostate Cancer
- Decipher® Testing
-
Bay Pines, Florida
- +2 more
May 27, 2022
Danish Prostate Cancer Consortium Study-1
Recruiting
- Prostate Cancer
-
Aarhus N, Aarhus, Denmark
- +2 more
Mar 1, 2023
Prostate Carcinoma Trial in Los Angeles (procedure, device, other)
Not yet recruiting
- Prostate Carcinoma
- Biospecimen Collection
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 6, 2023
Nevoid Basal Cell Carcinomas in Gorlin Syndrome
Enrolling by invitation
- Basal Cell Carcinoma
- Gorlin Syndrome
- Active surveillance
-
Oslo, NorwayOslo University Hospital
Jun 8, 2023
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- +10 more
- Regular care with additional administration of a semi-structured interview
-
Maastricht, NetherlandsMaastricht University Medical Center+
Sep 13, 2023
Treatment in Carriers of Rare Germline Mutations
Recruiting
- Prostate Cancer
-
Sutton, Surrey, United KingdomInstitute of Cancer Research and Royal Marsden Hospital
Mar 30, 2022
Inherited Risk of Developing Aggressive Prostate Cancer, PATROL
Recruiting
- Prostate Carcinoma
- Biospecimen Collection
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 12, 2022
Prostate Carcinoma Trial in United States (Multiparametric Magnetic Resonance Imaging)
Recruiting
- Prostate Carcinoma
- Multiparametric Magnetic Resonance Imaging
-
Phoenix, Arizona
- +43 more
Jun 30, 2022